Supplementary Data 1. Evaluation of SNV calls.
To check the quality of our variant calling algorithm on whole-exome sequencing (WES) and custom complementary CDS sequencing (CCCS) data, we genotyped the 7 samples using Illumina HumanOmniExpressExome SNP array, and compared them with NGS data. Of the 7 genotyped samples, all 7 had WES data available, and 2 had CCCS data available. For WES, an average of 243,573 genotype locations were comparable between the two datasets and 99.95% genotypes were concordant between WES calls and the SNP array ( Supplementary Table S7 ). We examined the 140 discordant calls for the NA18943 sample (SureSelectV4 WES data) using Sanger sequencing ( Supplementary Table S8 and Supplementary Table S9 ) and 77 of 140 genotypes were consistent with our NGS calls. Based on this validation, we estimate the false positive and false negative rate of our variant calling method for WES to be 0.021% (50 / 243,573) and 0.064% (13 / 20,375), respectively. Note that these rates are conservative estimations as the SNVs that could not be successfully determined using Sanger sequencing were counted as incorrect. Moreover, the test sample, NA18943 SureSelectV4 data, had the most discordant SNP calls of the set. In the same manner, we compared the genotype calls between the CCCS and the SNP array, and 26,168 locations from 2 samples were comparable between the two datasets. Forty locations were discordant and the observed concordance rate was 99.85% ( Supplementary Table   S10 ). We examined the 40 locations genotype with Sanger sequencing and found 24 were consistent with our NGS calls ( Supplementary Table S9 and Supplementary Table   S11 ). Based on this validation, we estimate the false positive and false negative rate of our variant calling algorithm in CCCS calling to be 0.038% (10 / 26,168) and 0.27% (6 / 2,203), respectively.
Supplementary Data 2. Clinical symptoms of affected individuals with
microcephaly with the compound heterozygous mutation identified in present study.
The family tree of the affected family with microcephaly is shown in Fig. 3a . The II-2 affected child was born by spontaneous delivery at 40 weeks of gestation after an uneventful pregnancy as the second child of healthy and non-consanguineous parents.
Her birth weight was 2,228 g (−2.0 SD) and her HC was 29 cm (−3.2 SD). She showed no dysmorphism except for microcephaly ( Fig. 3b ). She showed mild delay of language development, though her intelligence and motor functions were normal at 6 years of age.
Her HC was 42 cm (−6.6 SD) at 6 years of age. The affected child II-3 was a younger brother of II-2. He was born at 40 weeks of gestation with no asphyxia. His birth weight was 2,626 g and his HC was 29 cm (−3.2 SD). At the age of 3 years, his HC was 42 cm (−4.9 SD) and showed normal development. His physical and neurological findings were generally normal except microcephaly.
